With emerging biotechs playing a critical part in developing new drugs, Merck attempts to understand the interactions between parties when manufacturing monoclonal antibodies (mAbs).
The pharmaceutical industry is one that has arguably created more breakthrough feats of human endeavour than any other, but is it missing an important new breakthrough closer to home?
Alba Tiley, head of sustainability at Centrient Pharmaceuticals discusses why a sustainable to developing antibiotics is key to combatting antimicrobial resistance (AMR).
With the emergence of CBD-based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers through the bioavailability challenges facing this sector of the industry.
The world’s leading practitioners in genomics are now shaping a community of experts in Manchester. Health writer and Guardian contributor, Rachel Pugh, investigates the opportunities for local patients and international investors alike.
Rich Quelch, global head of marketing at pharmaceutical packaging provider Origin, discusses the rise in medicinal cannabis and what it means for the pharma market.
